MENU
AUTL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Autolus Therapeutics (AUTL) Earnings Date & Reports

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

AUTL is expected to report earnings to rise 188.44% to -25 cents per share on May 01

Autolus Therapeutics AUTL Stock Earnings Reports
Q1'25
Est.
$-0.26
Q4'24
Beat
by $0.12
Q3'24
Missed
by $0.10
Q2'24
Missed
by $0.03
Q1'24
Missed
by $0.16
The last earnings report on March 20 showed earnings per share of -9 cents, beating the estimate of -20 cents. With 1.14M shares outstanding, the current market capitalization sits at 441.77M.
View a ticker or compare two or three
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
471
Web
https://www.autolus.com